Potent Inhibition of CTLA-4 Expression by an Anti-CTLA-4 Ribozyme

Author： Cepero E. Hnatyszyn H.J. Kraus G. Lichtenheld M.G.

Publisher： Elsevier

ISSN： 0006-291X

Source： Biochemical and Biophysical Research Communications, Vol.247, Iss.3, 1998-06, pp. : 838-843

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Update on anti-CTLA-4 antibodies in clinical trials

By Langer Lee F Clay Timothy M Morse Michael A

Expert Opinion on Biological Therapy, Vol. 7, Iss. 8, 2007-08 ,pp. : 1245-1256

Informa Healthcare

Access to resources Recommend Favorite

An Mse I RFLP in the Human CTLA4 Promotor

By deichmann K. Heinzmann A. Bruggenolte E. Forster J. Kuehr J.

Biochemical and Biophysical Research Communications, Vol. 225, Iss. 3, 1996-08 ,pp. : 817-818

Elsevier

Access to resources Recommend Favorite

Molecular Weights of CTLA-4 and CD80 by Sedimentation Equilibrium Ultracentrifugation

By Fairman R. Fenderson W. Hail M.E. Wu Y. Shaw S-Y.

Analytical Biochemistry, Vol. 270, Iss. 2, 1999-06 ,pp. : 286-295

Elsevier

Access to resources Recommend Favorite

Src Family Tyrosine Kinases Associate with and Phosphorylate CTLA-4 (CD152)

By Miyatake S. Nakaseko C. Umemori H. Yamamoto T. Saito T.

Biochemical and Biophysical Research Communications, Vol. 249, Iss. 2, 1998-08 ,pp. : 444-448

Elsevier

Access to resources Recommend Favorite

CTLA4Ig: A Novel Immunoglobulin Chimera with Immunosuppressive Properties

By Peach R.J. Linsley P.S.

Methods, Vol. 8, Iss. 2, 1995-10 ,pp. : 116-123

Academic Press

Access to resources Recommend Favorite